Recent studies on fibroblasts from PD patients with endogenous expression of mutant PINK1 pointed to respiratory chain deficiencies and enhanced production of reactive oxygen species (ROS), but yielded heterogenous data on cellular ATP levels, activity of respiratory chain enzymes and antioxidant defense mechanisms [6], [7], [8], [9]. This evidence concerns the gene PINK1 and Parkinson disease.